Also trades as: EKTA-B.ST (STO) · $vol 7M · 0O5H.IL (IOB) · $vol 5M · EKTAF (OTC) · $vol 0M

$5.09

-0.04 (-0.78%)

Weekly Expected Move ±4.1%

$5 $5 $5 $5 $6

OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 41 · $1.9B mcap · 311M float · 0.0011% daily turnover · Short 31% of daily vol

Revenue

$16.4B -9.0% ▼

5Y CAGR: +3.6%

Gross Profit

$6.1B -9.2% ▼

5Y CAGR: +1.8%

Operating Income

$425M -52.2% ▼

5Y CAGR: -25.9%

Net Income

-$510M -315.1% ▼

EPS (Diluted)

$-1.29 -308.1% ▼

EBITDA

$1.6B -24.7% ▼

5Y CAGR: -11.7%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$14.5B	$16.9B	$18.1B	$18.0B	$16.4B
YoY Growth	+5.7%	+16.0%	+7.4%	-0.6%	-9.0%
Cost of Revenue	$9.1B	$10.5B	$11.3B	$11.3B	$10.3B
Gross Profit	$5.4B	$6.3B	$6.8B	$6.7B	$6.1B
Gross Margin	37.4%	37.6%	37.5%	37.4%	37.4%
R&D Expenses	$1.4B	$1.4B	$1.9B	$2.7B	$2.6B
SG&A Expenses	$2.5B	$3.0B	$3.0B	$3.1B	$3.2B
Operating Expenses	$3.9B	$4.5B	$4.8B	$5.9B	$5.7B
Operating Income	$1.6B	$1.4B	$2.0B	$890M	$425M
Operating Margin	11.3%	8.5%	11.3%	4.9%	2.6%
Interest Expense	$148M	$310M	$482M	$416M	$364M
Income Before Tax	$1.5B	$1.2B	$1.7B	$490M	-$133M
Tax Expense	$345M	$254M	$365M	$250M	$373M
Net Income	$1.2B	$943M	$1.3B	$237M	-$510M
Net Margin	7.9%	5.6%	7.2%	1.3%	-3.1%
EPS (Diluted)	$3.02	$2.47	$3.41	$0.62	$-1.29
EBITDA	$2.7B	$2.6B	$3.3B	$2.2B	$1.6B
Shares Outstanding	382M	382M	382M	382M	383M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$3.8B	$4.3B	$4.7B	$5.2B	$3.6B	$4.1B	$4.1B	$4.8B
Cost of Revenue	$2.4B	$2.8B	$3.0B	$3.1B	$2.3B	$2.5B	$2.6B	$2.9B
Gross Profit	$1.4B	$1.5B	$1.7B	$2.1B	$1.3B	$1.5B	$1.4B	$1.9B
Gross Margin	37.0%	35.5%	36.9%	39.8%	36.8%	37.8%	35.1%	39.5%
R&D Expenses	$438M	$421M	$443M	$1.4B	$438M	$434M	$500M	$1.2B
SG&A Expenses	$804M	$720M	$765M	$774M	$698M	$727M	$879M	$881M
Operating Expenses	$1.2B	$1.2B	$1.2B	$2.3B	$1.1B	$1.1B	$943M	$2.1B
Operating Income	$174M	$388M	$525M	-$197M	$219M	$390M	$483M	-$236M
Operating Margin	4.5%	8.9%	11.2%	-3.8%	6.0%	9.6%	11.9%	-5.0%
Interest Expense	$83M	$113M	$95M	$109M	$83M	$8M	$82M	$122M
Income Before Tax	$91M	$275M	$431M	-$307M	$136M	$310M	$959K	-$584M
Tax Expense	$20M	$61M	$95M	$74M	$30M	$81M	$10M	$281M
Net Income	$70M	$212M	$341M	-$386M	$107M	$230M	$10M	-$868M
Net Margin	1.8%	4.9%	7.3%	-7.5%	2.9%	5.7%	0.2%	-18.2%
EPS (Diluted)	$0.18	$0.55	$0.89	$-1.01	$0.28	$0.60	$0.03	$-2.30
EBITDA	$323M	$697M	$849M	$124M	$509M	$683M	$614M	$69M
Shares Outstanding	382M	382M	382M	382M	382M	383M	382M	384M

EKTAY OTC